Follow-up Dosing of Guideline-Indicated Medications After Myocardial Infarction: Insights from the Acute Myocardial Infarction Quality Assurance (AMIQA) Canada Study
Except for statins, most patients were not receiving target doses of indicated medications after MI with reduced LVEF. Follow-up dosing was not associated with LVEF reassessment or improvement in LVEF. Future quality-improvement initiatives may require distinct strategies for improving adherence to recommendations for medication dosing vs follow-up imaging.
Authors
- Stephen B. Wilton (ORCID: https://orcid.org/0000-0002-6344-312X)
- O. Chen
- Matthew T. Bennett (ORCID: https://orcid.org/0000-0002-3959-0074)
- Jaimie Manlucu (ORCID: https://orcid.org/0000-0001-9968-6388)
- Todd Wilson (ORCID: https://orcid.org/0000-0002-4345-0146)
Institutions
- Western University (CA)
- University of British Columbia (CA)
- University of Calgary (CA)
- Libin Cardiovascular Institute of Alberta (CA)
Publication Details
- Journal
- CJC Open
- Published
- 2025-10-28
- DOI
- https://doi.org/10.1016/j.cjco.2025.10.006
- Primary Topic
- Acute Myocardial Infarction Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Boston Scientific Corporation